Wells Fargo Upgrades Zimmer Biomet Holdings to Overweight, Raises Price Target to $123

Benzinga · 1d ago
Wells Fargo analyst Larry Biegelsen upgrades Zimmer Biomet Holdings (NYSE:ZBH) from Equal-Weight to Overweight and raises the price target from $113 to $123.